Ilex Medical Ltd (TLV:ILX)

Market Cap	745.69M
Revenue (ttm)	917.10M
Net Income (ttm)	43.64M
Shares Out	11.19M
EPS (ttm)	3.90
PE Ratio	16.67
Forward PE	n/a
Dividend	1.22 (1.83%)
Ex-Dividend Date	Apr 7, 2025

Volume	1,673
Average Volume	2,345
Open	6,667.00
Previous Close	6,667.00
Day's Range	6,600.00 - 6,741.00
52-Week Range	5,643.00 - 7,856.00
Beta	0.00
RSI	57.37
Earnings Date	Mar 26, 2026

About Ilex Medical

Ilex Medical Ltd engages in import, marketing, distribution, and sale of diagnostic products, kits, and consumables in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine, occult blood, calprotectin, LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1977
• Employees: 178
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ILX

Financial Performance

In 2024, Ilex Medical's revenue was 920.37 million, an increase of 0.45% compared to the previous year's 916.25 million. Earnings were 38.98 million, a decrease of -23.39%.